Call for Abstract

37th Conference on Preventive Oncology and Diagnostic Cancer, will be organized around the theme “Advancing Cancer Prevention and Early Detection: Innovations and Best Practices”

Preventive Oncology 2024 is comprised of 13 tracks and 0 sessions designed to offer comprehensive sessions that address current issues in Preventive Oncology 2024.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

This session will focus on various strategies and interventions aimed at reducing the risk of developing cancer, including lifestyle modifications, nutritional interventions, and physical activity recommendations.

  • Lifestyle Modifications and Cancer Risk Reduction
  • Nutritional Interventions in Cancer Prevention
  • Physical Activity and Cancer Prevention

This session will explore the role of vaccinations, such as HPV and hepatitis B vaccines, in preventing specific types of cancers. It will discuss the effectiveness of vaccines and their impact on cancer prevention.

  • HPV Vaccination and Cervical Cancer Prevention
  • Hepatitis B Vaccination and Liver Cancer Prevention
  • Emerging Vaccines in Cancer Prevention

This session will cover the importance of regular screenings, such as mammograms, colonoscopies, and Pap smears, in detecting cancer at an early and more treatable stage. It will discuss screening guidelines and best practices.

  • Screening Guidelines and Best Practices
  • Advances in Mammography and Breast Cancer Screening
  • Colonoscopy and Colorectal Cancer Screening
  • Prostate Cancer Screening: PSA Tests and Beyond

This session will focus on the role of genetic counseling and testing in identifying individuals at higher risk for cancer due to inherited genetic mutations. It will discuss the benefits and implications of genetic testing for cancer prevention.

  • Genetic Risk Assessment and Cancer Prevention
  • BRCA Mutations and Preventive Measures for Breast and Ovarian Cancer
  • Genetic Counseling: Ethical and Practical Considerations

This session will explore public health initiatives and policies aimed at cancer prevention. It will discuss community-based programs, health campaigns, and policy measures to reduce the burden of cancer.

  • Public Health Campaigns and Cancer Awareness
  • Health Policy and Cancer Prevention Programs
  • Community-based Cancer Prevention Initiatives

This session will discuss the use of drugs and agents to reduce the risk of cancer development. It will cover clinical trials, emerging therapies, and the benefits and risks of chemoprevention.

  • Drugs and Agents in Cancer Prevention
  • Clinical Trials in Chemoprevention
  • Benefits and Risks of Chemoprevention

This session will highlight recent advancements in diagnostic imaging technologies, such as mammography, MRI, and CT scans, for detecting cancer. It will discuss the role of imaging in early diagnosis and treatment planning.

  • Innovations in Mammography, MRI, and CT Scans
  • PET Scans in Cancer Detection and Monitoring
  • Ultrasound Techniques in Cancer Diagnosis

This session will focus on biopsy techniques and histopathological examination for diagnosing cancer. It will discuss the role of pathologists and surgeons in obtaining and analyzing tissue samples.

  • Techniques in Biopsy and Tissue Sampling
  • Pathological Examination and Cancer Diagnosis
  • Role of Immunohistochemistry in Cancer Diagnosis

This session will cover the use of molecular and genetic tests for diagnosing cancer. It will discuss genomic profiling, liquid biopsies, and biomarkers used in cancer diagnosis.

  • Genomic Profiling and Cancer Diagnosis
  • Liquid Biopsies: Techniques and Applications
  • Biomarkers in Cancer Detection and Prognosis

This session will discuss the role of laboratory tests, such as blood tests and cytology, in cancer diagnosis. It will cover the latest advancements in laboratory diagnostics for cancer detection.

  • Blood Tests and Cancer Markers
  • Advances in Cytology and Cancer Detection
  • Role of Laboratory Medicine in Cancer Diagnosis

This session will explore emerging technologies, such as digital tools and AI, used in cancer screening. It will discuss non-invasive and minimally invasive screening methods and their applications.

  • Emerging Technologies in Cancer Screening
  • Digital Tools and Artificial Intelligence in Cancer Diagnosis
  • Non-invasive and Minimally Invasive Screening Methods

This session will highlight the importance of multidisciplinary collaboration in cancer diagnosis. It will discuss case studies and collaborative approaches among radiologists, pathologists, and oncologists.

  • Integrating Diagnostic Techniques for Comprehensive Care
  • Collaboration Among Radiologists, Pathologists, and Oncologists
  • Case Studies in Multidisciplinary Cancer Diagnosis

This session will focus on improving patient care and outcomes through effective diagnostic pathways. It will discuss ethical considerations, patient perspectives, and best practices in cancer diagnosis and care.

  • Improving Diagnostic Accuracy and Patient Outcomes
  • Navigating the Diagnostic Pathway: Patient Perspectives
  • Ethical Considerations in Cancer Diagnosis

These sessions aim to provide a comprehensive overview of preventive oncology and diagnostic cancer, covering various aspects of cancer prevention, early detection, and diagnosis.